Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2013 (2013), Article ID 670836, 13 pages
http://dx.doi.org/10.1155/2013/670836
Research Article

Design of Thymidine Analogues Targeting Thymidilate Kinase of Mycobacterium tuberculosis

1Laboratory for Simulations and Biomolecular Physics, Advanced Teachers Training College, University of Yaoundé I, P.O. Box 47, Yaoundé, Cameroon
2Centre for Atomic Molecular Physics and Quantum Optics (CEPAMOQ), University of Douala, P.O. Box 8580, Douala, Cameroon
3International Centre for Science and High Technology, UNIDO, Area Science Park, Padriciano 99, 34012 Trieste, Italy
4Laboratoire de Physique Fondamentale et Appliquée, Université d’Abobo-Adjamé, 02 BP 801 Abidjan 02, Cote d’Ivoire
5Cancer Research Institute, Slovak Academy of Sciences, 83391 Bratislava, Slovakia
6Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University, 83232 Bratislava, Slovakia
7International Centre for Applied Research and Sustainable Technology (ICARST), 81404 Bratislava, Slovakia
8Faculty of Natural Sciences, University of Ss. Cyril and Methodius, 91701 Trnava, Slovakia

Received 30 November 2012; Accepted 12 December 2012

Academic Editor: José R. Lapa e Silva

Copyright © 2013 Luc Calvin Owono Owono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • M. Keita, A. Kumar, B. Dali, E. Megnassan, M. I. Siddiqi, V. Frecer, and S. Miertus, “Quantitative structure–activity relationships and design of thymine-like inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis with favourable pharmacokinetic profiles,” RSC Adv., vol. 4, no. 99, pp. 55853–55866, 2014. View at Publisher · View at Google Scholar
  • Affiba Kouassi, Mawa Kone, Melalie Keita, Akori Esmel, Eugene Megnassan, Yao N’Guessan, Vladimir Frecer, and Stanislav Miertus, “Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles,” International Journal of Molecular Sciences, vol. 16, no. 12, pp. 29744–29771, 2015. View at Publisher · View at Google Scholar